DocSym
β
Searchsearch
Search
(D69) Purpura and other haemorrhagic conditions
More details coming soon
2 006 370 in individuals diagnosis purpura and other haemorrhagic conditions confirmed
32 024 deaths with diagnosis purpura and other haemorrhagic conditions
2% mortality rate associated with the disease purpura and other haemorrhagic conditions
Diagnosis purpura and other haemorrhagic conditions is diagnosed Women are 1.21% more likely than Men
991 025
Men receive the diagnosis purpura and other haemorrhagic conditions
14 197 (1.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 015 345
Women receive the diagnosis purpura and other haemorrhagic conditions
17 827 (1.8 %)Died from this diagnosis.
Risk Group for the Disease purpura and other haemorrhagic conditions - Men and Women aged 5-9
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features purpura and other haemorrhagic conditions
Absence or low individual and public risk
Purpura and other haemorrhagic conditions - what does this mean
Purpura and other haemorrhagic conditions are caused by a decrease in the clotting factors in the blood, leading to an increased risk of bleeding. this can be caused by a number of factors, including certain medications, underlying diseases such as liver disease, or vitamin k deficiency. in some cases, the cause is unknown.
What happens during the disease - purpura and other haemorrhagic conditions
Purpura and other haemorrhagic conditions are caused by a breakdown in the normal clotting process. this is usually due to a deficiency in clotting factors, such as platelets, or a problem with the vessels themselves, such as a weakened vessel wall or increased fragility. this can lead to the abnormal leakage of blood from the vessels, resulting in the characteristic purpura lesions. in some cases, an underlying medical condition, such as an autoimmune disorder, can also be responsible for the clotting process disruption.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC)
- Blood smear
- Coagulation studies
- Platelet count
- Serum protein electrophoresis
- Urine analysis
- Liver function tests
- Kidney function tests
- Thyroid function tests
- Imaging studies (CT scan, MRI, etc.)
- Bone marrow biopsy
- Skin biopsy
- Tissue biopsy
Treatment and Medical Assistance
Main goal: To reduce the risk of bleeding and/or to stop the bleeding.
- Administering vitamin K to help the blood clot
- Prescribing anticoagulant drugs such as heparin and warfarin
- Giving platelet transfusions to replace missing platelets
- Using fresh frozen plasma to replace the clotting factors
- Prescribing corticosteroids to reduce inflammation
- Administering immunoglobulins to reduce immune system activity
- Performing surgery to repair damaged blood vessels
- Giving blood transfusions to replace lost red blood cells
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Purpura and other haemorrhagic conditions - Prevention
Prevention of purpura and other haemorrhagic conditions involves avoiding activities that may lead to trauma, such as contact sports, and taking measures to reduce the risk of infection, such as avoiding contact with people who are ill. it is also important to maintain a healthy lifestyle, including a nutritious diet, regular exercise, and avoidance of smoking and excessive alcohol use.